trending Market Intelligence /marketintelligence/en/news-insights/trending/5UfsjAbc6rXyV9YdpmLprw2 content esgSubNav
In This List

Real Nutriceutical H1 profit falls YOY


Private Markets 360 | Episode 6: Benchmarking private investment performance

Case Study

A European Bank Leverages an AIF Scorecard to Help Meet Basel Regulatory Requirements

Case Study

Powering the markets of the future with data and AI


Analyzing Sentiment in Quarterly Earnings Calls — Q3 2023

Real Nutriceutical H1 profit falls YOY

Real Nutriceutical Group Ltd said its first-half normalized net income came to 4 fen per share, a decrease of 75.6% from 18 fen per share in the year-earlier period.

Normalized net income, which excludes unusual gains or losses on a pre- and after-tax basis, was 69.2 million yuan, a decrease of 69.4% from 226.3 million yuan in the year-earlier period.

Total revenue fell 40.5% on an annual basis to 649.2 million yuan from 1.09 billion yuan, and total operating expenses decreased 25.7% on an annual basis to 538.4 million yuan from 724.7 million yuan.

Reported net income fell 72.2% from the prior-year period to 68.5 million yuan, or 4 fen per share, from 246.7 million yuan, or 19 fen per share.

As of Sept. 22, US$1 was equivalent to 6.67 yuan.